Below is a list of select startups that are tenants in the Venture Accelerator utilizing the expertise and full suite of business services of Tech Transfer’s Venture Center.

Arborsense Arborsense

Arborsense

2020

Transdermal bio sensor for alcohol and drug monitoring for court-mandated programs and other applications

Cartox Cartox

Cartox

In vitro cardiotoxicity testing platform using mature human stem cell derived cardiomyocytes

CubeWorks CubeWorks

CubeWorks

2019

CubeWorks has been leading revolutionary advances in ultra-low power computing through its CubiSens™ platform, the first truly autonomous wireless sensing platform in a millimeter-scale footprint.

Elegus Elegus

Elegus

2016

Elegus is commercializing an aramid-based, ultra-strong battery separator made from high-performance nano-scale fibers. We believe our separator is thin and strong enough to enable lithium-ion batteries to increase energy density without compromising safety

Endectra Endectra

Endectra

Endectra LLC is commercializing solid-state, real-time radiation detection technology to displace expensive crystal- and gas-based sensors in defense, industrial, and medical applications.

G-HMRC G-HMRC

G-HMRC

The G-HMRC will provide health risk assessment (HRA) services and products as a multi-channel intelligent communication tool for health management decision support and will continue to advance our offerings through ongoing research and technology developments.

GreenMark Biomedical GreenMark Biomedical

GreenMark Biomedical

2019

Enabling dentists to preserve teeth through early diagnosis and treatment

InheRET InheRET

InheRET

2019

Risk evaluation tool uses your personal and family health history to find out if you are at increased risk for hereditary disease using easy-to-read report with next-step recommendations helps you and your doctor make a care plan to reduce your risk

Mekanistic Therapeutics Mekanistic Therapeutics

Mekanistic Therapeutics

Mekanistic Therapeutics designs and discovers anti-cancer agents that inhibit multiple cancer drivers.  Our lead agent, MTX-211 is a potent and selective dual inhibitor of two frequently aberrant cancer drivers. It is effective against a number of cancer types generally resistant to monotherapy alone.

MemryX MemryX

MemryX

2019

Designs neural network inference chips with unparalleled energy efficiency and compute density for edge computing, IoT, mobile, and more

MPhasics MPhasics

MPhasics

2018

Nanoparticle fabrication

Omniscent Omniscent

Omniscent

2018

Handheld MEMS-based VOC sensor system capable of detecting 20 VOC gases simultaneously

ONL Therapeutics ONL Therapeutics

ONL Therapeutics

2014

FAS apoptosis inhibitors to protect photoreceptors and preserve patient vision from retinal diseases.  ONL is focused on preventing the death of key retinal cells, including photoreceptors—the root cause of vision loss and the leading cause of blindness.

Opsidio, LLC Opsidio, LLC

Opsidio, LLC

2015

Therapeutic monoclonal antibody for pulmonary fibrosis/asthma/fibrotic lung disease

Phenomics Heatlh Phenomics Heatlh

Phenomics Heatlh

2018

Precision clinical treatment support products and services based on advanced pharmacoepigenomics